Teva announces intention to divest api business as part of pivot to growth strategy

Tel aviv, israel--(business wire)--teva announced today its intention to divest its active-pharmaceutical ingredient (api) business, or "tapi". tapi is a global leader in the small-molecule api industry, with approximately 4,300 employees worldwide. the intent to divest “tapi” will allow teva to maximize current and potential revenue streams, focusing on capital reallocation towards growth and innovation, and to better serve patients. the intended divestiture is expected to create additional va.
TEVA Ratings Summary
TEVA Quant Ranking